top of page

Meet The Team


Chief Executive Officer


Eric Berreklouw

Chief Medical Officer

Eric Berreklouw (Chief Medical Officer) is the inventor of the AnchorValve technology. Dr Berreklouw practised as a cardiac surgeon for 40 years, holds several patents related to heart valve prostheses, and has extensive experience with research into sutureless heart valve prostheses.


John McKenna

Business Development Advisor

John McKenna (Business Development Advisor) is Director of Clinical Marketing at Aortech, with 30 years of experience with cardiac surgery manufacturers, including Vascutek and start up companies.


Peter Duijst

VP Regulatory and Clinical Affairs

Peter Duijst (Regulatory and Clinical Affairs) has over 25 years of experience in bringing cardiovascular devices to market. Amongst these were devices related to endovascular repair (EVT), and more recently transcatheter heart valve replacement (JenaValve), and rapid deployment aortic valve replacement (Edwards).


Nicolas van Mieghem

Member Scientific Advisory Board

Nicolas van Mieghem is an experienced and well recognized invasive cardiologist and researcher at the Thoraxcenter University Medical Center, Rotterdam, The Netherlands with broad experience with transcatheter treatment of valvular heart diseases.

bottom of page